Amid heightened global trade tensions and economic uncertainty, European markets have experienced significant declines, with the STOXX Europe 600 Index seeing its largest drop in five years. In such volatile conditions, companies with strong insider ownership can be appealing to investors as this often indicates confidence from those closest to the business.
Name | Insider Ownership | Earnings Growth |
Pharma Mar (BME:PHM) | 11.8% | 40.8% |
Vow (OB:VOW) | 13.1% | 111.2% |
Elicera Therapeutics (OM:ELIC) | 28.3% | 97.2% |
Bergen Carbon Solutions (OB:BCS) | 12% | 50.8% |
Lokotech Group (OB:LOKO) | 13.9% | 58.1% |
Nordic Halibut (OB:NOHAL) | 29.8% | 56.3% |
CD Projekt (WSE:CDR) | 29.7% | 36.8% |
Elliptic Laboratories (OB:ELABS) | 22.6% | 88.2% |
Ortoma (OM:ORT B) | 27.7% | 68.6% |
Circus (XTRA:CA1) | 26% | 51.4% |
Click here to see the full list of 228 stocks from our Fast Growing European Companies With High Insider Ownership screener.
Let's uncover some gems from our specialized screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Moltiply Group S.p.A. is a holding company in the financial services industry with a market cap of €1.42 billion.
Operations: The company's revenue segments include €221.12 million from the Mavriq Division and €232.86 million from Moltiply BPO&Tech.
Insider Ownership: 22.9%
Moltiply Group S.p.A. demonstrates robust growth potential with earnings forecasted to rise significantly at 26.21% annually, outpacing the Italian market's 7.6%. Despite a high debt level, its revenue is projected to grow at 15% per year, surpassing the local market average of 4.1%. Recent financials show an increase in sales from €414.02 million to €469.17 million and net income from €34.69 million to €41.71 million for fiscal year-end 2024, highlighting solid performance momentum without recent insider trading activity influencing stock dynamics.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Getinge AB (publ) is a company that offers products and solutions for operating rooms, intensive-care units, and sterilization departments both in Sweden and globally, with a market cap of SEK52.98 billion.
Operations: Getinge's revenue segments comprise Life Science at SEK4.55 billion, Acute Care Therapies at SEK17.95 billion, and Surgical Workflows (excluding Life Science) at SEK12.26 billion.
Insider Ownership: 20.4%
Getinge shows potential as a growth company with significant insider ownership, despite challenges in profit margins, which decreased from 7.6% to 4.7%. The company's earnings are forecasted to grow significantly at 22.2% annually, outpacing the Swedish market's average of 9.4%. Recent innovations like the Neural Pressure Support for ICU ventilation and DPTE®-FLEX port enhance its product offerings. However, an unstable dividend track record and lower-than-expected return on equity remain concerns.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: VAT Group AG, along with its subsidiaries, specializes in the development, manufacturing, and sale of vacuum and gas inlet valves, multi-valve modules, motion components, and edge-welded metal bellows with a market capitalization of CHF8.05 billion.
Operations: The company's revenue is primarily generated from its Valves segment, which accounts for CHF842.76 million, followed by the Global Service segment at CHF167.53 million.
Insider Ownership: 10.2%
VAT Group demonstrates growth potential with substantial insider ownership. The company reported a rise in 2024 sales to CHF 942.2 million and net income of CHF 211.8 million, reflecting robust financial performance. Forecasts suggest earnings and revenue will grow faster than the Swiss market at 18.6% and 12.4% annually, respectively, though not significantly high by some standards. Despite volatile share prices recently, VAT trades below its estimated fair value with analyst consensus predicting a price increase of over 40%.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include BIT:MOL OM:GETI B and SWX:VACN.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。